Home/Nitinotes/Lloyd Diamond

LD

Lloyd Diamond

CEO

Therapeutic Areas

Obesity Metabolic disease

Nitinotes Pipeline

Drug	Indication	Phase
EndoZip™	Endoscopic gastroplasty for class I‑II obesity	IDE/comparative study

Leadership Team at Nitinotes

CTO & Chief Global Support

VP Clinical, RA & QA

Ishaq Zighelnic

VP R&D & Engineering

Ishay Zighelnic

VP Supply Chain

View full Nitinotes profile